newsfilter
← Latest News
Business Wire·

Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Increased All-Cash Tender Offer Price of $21.80 per share – or $153.2 Million New Tender Offer Price Represents 21.1% Premium to Prior Offer Assertio Holdings, Inc. (NASDAQ:ASRT) ("Assertio" or the "Company") today